Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBIT Margin: 2013-2018

Historic EBIT Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to 829.08%.

  • Armata Pharmaceuticals' EBIT Margin rose 1265408.00% to 829.08% in Q4 2018 from the same period last year, while for Dec 2018 it was 2,413.06%, marking a year-over-year increase of 1646176.00%. This contributed to the annual value of 762.14% for FY2024, which is 291085.00% up from last year.
  • As of Q4 2018, Armata Pharmaceuticals' EBIT Margin stood at 829.08%, which was up 4.79% from 791.21% recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' EBIT Margin registered a high of 10,901.14% during Q2 2018, and its lowest value of -53,927.27% during Q4 2016.
  • Its 3-year average for EBIT Margin is -10,987.69%, with a median of -4,262.26% in 2016.
  • As far as peak fluctuations go, Armata Pharmaceuticals' EBIT Margin skyrocketed by 7,295,469bps in 2014, and later plummeted by 5,163,040bps in 2016.
  • Armata Pharmaceuticals' EBIT Margin (Quarterly) stood at -2,571.29% in 2014, then spiked by 27,441bps to -2,296.88% in 2015, then crashed by 5,163,040bps to -53,927.27% in 2016, then surged by 4,210,227bps to -11,825.00% in 2017, then spiked by 1,265,408bps to 829.08% in 2018.
  • Its last three reported values are 829.08% in Q4 2018, 791.21% for Q3 2018, and 10,901.14% during Q2 2018.